Staf van Reet
Chief Executive Officer chez Viziphar Biosciences BV
Profil
Staf van Reet is the founder of Movetis NV, Viziphar Biosciences BVBA.
He currently holds the following positions: Chairman at Intrexon ActoBiotics NV, Executive Chairman at DoseVue NV, Independent Chairman at DeuterOncology SA, Director at Vlaams Instituut voor Biotechnologie - Flanders Institute, Non-Executive Director at Biocartis SA, Director at Vivactis NV, and Member at Het Vlaams Parlement.
In the past, Dr. van Reet has served as Chairman-Supervisory Board at Dr. Reddy's Research & Development BV, Chairman at Oxurion NV from 2013 to 2017, Chairman at Aratana Therapeutics NV, Chairman at FlandersBio vzw, Managing Director at Janssen Pharmaceutica NV, Director at Antwerps Innovatie Centrum-Antwerp Innovation Centre, Non-Executive Director at TheraSolve NV, Non-Executive Director at Biocartis Group NV, Vice President at Johnson & Johnson Innovation - JJDC, Inc. from 2000 to 2004, Vice President-Corporate Development at Galapagos Genomics NV in 2005, and President at The Janssen Research Foundation from 1989 to 1999.
Dr. van Reet's education includes a graduate and doctorate degree from Katholieke Universiteit Leuven and a graduate degree from the University of Antwerp.
Postes actifs de Staf van Reet
| Sociétés | Poste | Début |
|---|---|---|
| Viziphar Biosciences BV | Chief Executive Officer | 26/12/2012 |
Vlaams Instituut voor Biotechnologie - Flanders Institute
 Vlaams Instituut voor Biotechnologie - Flanders Institute Other Consumer ServicesConsumer Services Vlaams Instituut voor Biotechnologie - Flanders Institute operates as a non-profit organization, provides research and development services. It specializes in translating basic scientific results into pharmaceutical, agricultural and industrial applications. The company was founded on January 1, 1996 and is headquartered in Ghent, Belgium. | Director/Board Member | 04/10/2010 |
| Vivactis NV | Director/Board Member | 04/10/2010 |
Intrexon ActoBiotics NV
 Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium. | Chairman | - |
Biocartis SA
 Biocartis SA Medical SpecialtiesHealth Technology Biocartis SA develops molecular diagnostic solutions. It focuses on Oncology. The firm’s products include Idylla and Oncology assays and mutation tests. It also provides instant access to personalized medicine for patients. The company was founded by Rudi Pauwels in 2007 and is headquartered in Lausanne, Switzerland. | Director/Board Member | 02/07/2007 |
| Het Vlaams Parlement | Corporate Officer/Principal | - |
DoseVue NV
 DoseVue NV Medical SpecialtiesHealth Technology DoseVue NV is developing innovative technologies for convenient and accurate in-vivo dosimetry. It offers DoseWire Series 100 & DoseWire Series 200. The company was founded by Emiliano D Agostino in March 2013 and is headquartered in Turnhout, Belgium. | Chairman | - |
DeuterOncology SA
 DeuterOncology SA BiotechnologyHealth Technology DeuterOncology SA is a Belgian preclinical-stage biotechnology company that specializes in developing targeted cancer therapies. DeuterOncology is based in Liege, BE. The company's focus is on creating a first-in-class dual MET and RAS pathway inhibitor. The company was founded in 2020 by Timothy Perera, who has been the CEO since 2020. | Chairman | - |
Anciens postes connus de Staf van Reet
| Sociétés | Poste | Fin |
|---|---|---|
| OXURION NV | Chairman | 15/06/2017 |
| ░░░░░░░ ░░ | ░░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░ ░░░░░░░ ░░░░░░░░░░ ░ ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░ ░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ | - |
Formation de Staf van Reet
| Katholieke Universiteit Leuven | Doctorate Degree |
| University of Antwerp | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| OXURION NV | Health Technology |
| BIOCARTIS GROUP NV | Health Technology |
| Entreprise privées | 17 |
|---|---|
Johnson & Johnson Innovation - JJDC, Inc.
 Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Finance |
Dr. Reddy's Research & Development BV
 Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Dr. Reddy's Research & Development BV is engaged in the development and manufacture of injectable pharmaceutical products. It provides formulation, development, drug delivery, and clinical material manufacturing services to biotech and pharmaceutical companies worldwide. The company was founded by Joost J. M. Holthuis on July 20, 1995 and is headquartered in Leiden, Netherlands. | Health Technology |
Galapagos Genomics NV
 Galapagos Genomics NV Pharmaceuticals: MajorHealth Technology Galapagos is a discovery company focused on the identification of disease modifying drug targets by functionally screening human disease models and the subsequent progression of these targets into drug discovery. Galapagos is a genomics based drug discovery company with programs in osteoporosis, rheumatoid arthritis, osteoarthritis, Alzheimer's disease and asthma. | Health Technology |
Intrexon ActoBiotics NV
Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium. | Health Technology |
Movetis NV
 Movetis NV Pharmaceuticals: GenericHealth Technology Movetis NV operates as a pharmaceutical company, that focuses on the discovery, development, and commercialization of drugs for the treatment of diseases in the gastrointestinal (GI) area. Its products address GI disorders, such as severe chronic constipation, ascites, and paediatric reflux, as well as severe forms of GI motility disorders, including refractory gastro-oesophageal reflux disease. The company was founded in November 2006 and is headquartered in Turnhout, Belgium. | Health Technology |
Janssen Pharmaceutica NV
 Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Janssen Pharmaceutica NV engages in the development of medical solutions. It offers research and development services in the field of mental illness, neurological disorders, anesthesia, analgesia, gastrointestinal disorders, fungal infection, allergies and cancer. The firms products include Zytiga, Caelyx, Dacogen, Edurant, Fentanyl-Janssen, Intelence, Leustatin, , Pariet, and Reminyl. The company was founded in 1953 by Paul Janssen and is headquartered in Beerse, Belgium. | Health Technology |
Antwerps Innovatie Centrum-Antwerp Innovation Centre
 Antwerps Innovatie Centrum-Antwerp Innovation Centre Miscellaneous Commercial ServicesCommercial Services Antwerps Innovatie Centrum NV provides business planning services. Its activities include market studies, juridical support of projects, contract platform between the industry and the knowledge institutes of Antwerp and logistic support. The company is headquartered in Antwerpen, Belgium. | Commercial Services |
| The Janssen Research Foundation | |
Aratana Therapeutics NV
 Aratana Therapeutics NV Pharmaceuticals: OtherHealth Technology Aratana Therapeutics NV engages in the development and marketing of veterinary medicine. It offers Entyce, nocita, and Galliprant. The company was founded on December 20, 2007 and is headquartered in Leuven, Belgium. | Health Technology |
FlandersBio vzw
 FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen. | Commercial Services |
Biocartis SA
Biocartis SA Medical SpecialtiesHealth Technology Biocartis SA develops molecular diagnostic solutions. It focuses on Oncology. The firm’s products include Idylla and Oncology assays and mutation tests. It also provides instant access to personalized medicine for patients. The company was founded by Rudi Pauwels in 2007 and is headquartered in Lausanne, Switzerland. | Health Technology |
| Het Vlaams Parlement | |
| Viziphar Biosciences BV | |
| Vivactis NV | Miscellaneous |
TheraSolve NV
 TheraSolve NV BiotechnologyHealth Technology TheraSolve NV operates as a medical technology company that develops and commercializes solutions to promote medication adherence. The firm develops MemoPatch, an electronic reminder system that supports and motivates patients to take their medication regularly. The company was founded by Wim de Geest, Jan de Geest, Denise de Geest, Sabina de Geest, Corrine Flejou and Jan van Driessche in 2009 and is headquartered in Diepenbeek, Belgium. | Health Technology |
DoseVue NV
DoseVue NV Medical SpecialtiesHealth Technology DoseVue NV is developing innovative technologies for convenient and accurate in-vivo dosimetry. It offers DoseWire Series 100 & DoseWire Series 200. The company was founded by Emiliano D Agostino in March 2013 and is headquartered in Turnhout, Belgium. | Health Technology |
DeuterOncology SA
DeuterOncology SA BiotechnologyHealth Technology DeuterOncology SA is a Belgian preclinical-stage biotechnology company that specializes in developing targeted cancer therapies. DeuterOncology is based in Liege, BE. The company's focus is on creating a first-in-class dual MET and RAS pathway inhibitor. The company was founded in 2020 by Timothy Perera, who has been the CEO since 2020. | Health Technology |
